好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | C60 - Update in Acute Seizure Management and Status Epilepticus

Sunday 04/06/25
01:00 PM - 03:00 PM PDT Add To Calendar
San Diego Convention Center | 29CD
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Clio A. Rubinos, MD
Epilepsy/Clinical Neurophysiology (EEG)
Participants should comprehend the scientific principle of timely and appropriate dose administration of anti-seizure medications to halt status epilepticus and prevent disease progression effectively. We will explore the implementation and utility of seizure protocol ("Code Seizure") and will delve into the clinical implications, management strategies, and patient outcomes for acute symptomatic seizures and challenging EEG patterns such as periodic discharges and the Ictal Interictal Continuum.
 
This program is supported in part by an educational grant from Neurelis
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM PDT Introduction Introduction
Clio A. Rubinos, MD
01:05 PM - 01:30 PM PDT Speaker Time is Brain: Innovating Status Epilepticus Management with Seizure Code Implementation
Camilo Espinoza, MD
01:30 PM - 01:55 PM PDT Speaker Acute Symptomatic Seizure: What We Know and What's Next
Clio A. Rubinos, MD
01:55 PM - 02:20 PM PDT Speaker Repetitive or Periodic Patterns and Ictal-Interictal Continuum: Diagnosis and Management
Aaron F. Struck, MD
02:20 PM - 02:45 PM PDT Discussion Decoding the Grey Zones: Dilemmas in Managing Status Epilepticus and the Ictal-Interictal Continuum
Clio A. Rubinos, MD
02:45 PM - 03:00 PM PDT Q&A Questions and Answers
Clio A. Rubinos, MD, Aaron F. Struck, MD, Camilo Espinoza, MD
Faculty Disclosures
Clio A. Rubinos, MD Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qualtrics Inc. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity Pharmaceuticals. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Epilepsy Society . Dr. Rubinos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Marinus Pharmaceutical. Dr. Rubinos has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for American Epilepsy Society . The institution of Dr. Rubinos has received research support from University of North Carolina .
Aaron F. Struck, MD The institution of Dr. Struck has received research support from Ceribell.
Camilo Espinoza, MD Dr. Espinoza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Espinoza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopas Laboratories. Dr. Espinoza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Espinoza has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biopas Laboratories. The institution of Dr. Espinoza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Espinoza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biopas Laboratories. Dr. Espinoza has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott.